• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于HLA-Ig的人工抗原呈递细胞:设定相互作用的条件

HLA-Ig-based artificial antigen-presenting cells: setting the terms of engagement.

作者信息

Oelke Mathias, Schneck Jonathan P

机构信息

Department of Pathology and Medicine, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA.

出版信息

Clin Immunol. 2004 Mar;110(3):243-51. doi: 10.1016/j.clim.2003.11.014.

DOI:10.1016/j.clim.2003.11.014
PMID:15047202
Abstract

Recent advances in molecular medicine have shown that soluble MHC-multimers can be valuable tools for both the stimulation of as well as the analysis of antigen-specific T cells in vitro. In this review, we describe the use of dimeric major histocompatibility complexes, HLA-Ig, to visualize antigen-specific T cells as well as their potential to stimulate immune responses as part of an artificial antigen-presenting cell (aAPC). The use of HLA-Ig-based aAPC represents an exciting new approach to generate antigen-specific CTL for adoptive immunotherapy that helps to overcome many of the obstacles associated with limitations in current approaches to adoptive immunotherapy.

摘要

分子医学的最新进展表明,可溶性MHC多聚体在体外刺激和分析抗原特异性T细胞方面可成为有价值的工具。在本综述中,我们描述了二聚体主要组织相容性复合体HLA-Ig用于可视化抗原特异性T细胞的用途,以及其作为人工抗原呈递细胞(aAPC)的一部分刺激免疫反应的潜力。基于HLA-Ig的aAPC的应用代表了一种令人兴奋的新方法,可用于生成用于过继性免疫治疗的抗原特异性CTL,有助于克服与当前过继性免疫治疗方法局限性相关的许多障碍。

相似文献

1
HLA-Ig-based artificial antigen-presenting cells: setting the terms of engagement.基于HLA-Ig的人工抗原呈递细胞:设定相互作用的条件
Clin Immunol. 2004 Mar;110(3):243-51. doi: 10.1016/j.clim.2003.11.014.
2
Peptide-beta2-microglobulin-major histocompatibility complex expressing cells are potent antigen-presenting cells that can generate specific T cells.表达肽-β2-微球蛋白-主要组织相容性复合体的细胞是能够产生特异性T细胞的高效抗原呈递细胞。
Immunology. 2007 Sep;122(1):90-7. doi: 10.1111/j.1365-2567.2007.02616.x. Epub 2007 Apr 30.
3
Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig-coated artificial antigen-presenting cells.通过 HLA-Ig 包被的人工抗原呈递细胞进行抗原特异性细胞毒性 T 细胞的体外诱导和扩增。
Nat Med. 2003 May;9(5):619-24. doi: 10.1038/nm869. Epub 2003 Apr 21.
4
Overview of a HLA-Ig based "Lego-like system" for T cell monitoring, modulation and expansion.基于 HLA-Ig 的“乐高式系统”用于 T 细胞监测、调节和扩增的概述。
Immunol Res. 2010 Jul;47(1-3):248-56. doi: 10.1007/s12026-009-8156-z.
5
HLA Tetramer Based Artificial Antigen-Presenting Cells Efficiently Stimulate CTLs Specific for Malignant Glioma.基于HLA四聚体的人工抗原呈递细胞可有效刺激针对恶性胶质瘤的细胞毒性T淋巴细胞。
Clin Cancer Res. 2007 Dec 15;13(24):7329-34. doi: 10.1158/1078-0432.CCR-07-1025.
6
Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells.人工抗原呈递细胞诱导人细胞毒性T淋巴细胞
Nat Biotechnol. 2000 Apr;18(4):405-9. doi: 10.1038/74455.
7
Artificial antigen-presenting cells transduced with telomerase efficiently expand epitope-specific, human leukocyte antigen-restricted cytotoxic T cells.用端粒酶转导的人工抗原呈递细胞能有效扩增表位特异性、人类白细胞抗原受限的细胞毒性T细胞。
Cancer Res. 2005 Jun 15;65(12):5417-27. doi: 10.1158/0008-5472.CAN-04-2991.
8
HLA-Ig based artificial antigen presenting cells for efficient ex vivo expansion of human CTL.基于HLA-Ig的人工抗原呈递细胞用于人细胞毒性T淋巴细胞的高效体外扩增。
J Vis Exp. 2011 Apr 11(50):2801. doi: 10.3791/2801.
9
Promiscuity of the AlloHLA-A2 restricted T cell repertoire hampers the generation of minor Histocompatibility antigen-specific cytotoxic T cells across HLA barriers.同种异体 HLA-A2 限制性 T 细胞库的混杂性阻碍了跨 HLA 屏障产生次要组织相容性抗原特异性细胞毒性 T 细胞。
Biol Blood Marrow Transplant. 2007 Feb;13(2):151-63. doi: 10.1016/j.bbmt.2006.10.025.
10
Long-lived antitumor CD8+ lymphocytes for adoptive therapy generated using an artificial antigen-presenting cell.利用人工抗原呈递细胞产生用于过继性治疗的长寿抗肿瘤CD8+淋巴细胞。
Clin Cancer Res. 2007 Mar 15;13(6):1857-67. doi: 10.1158/1078-0432.CCR-06-1905.

引用本文的文献

1
Emerging approaches for T cell-stimulating platform development.T细胞刺激平台开发的新兴方法。
Cell Syst. 2024 Dec 18;15(12):1198-1208. doi: 10.1016/j.cels.2024.11.007.
2
Clinical significance, tumor immune landscape and immunotherapy responses of ADAR in pan-cancer and its association with proliferation and metastasis of bladder cancer.ADAR 在泛癌中的临床意义、肿瘤免疫图谱和免疫治疗反应及其与膀胱癌增殖和转移的关系。
Aging (Albany NY). 2023 Jul 6;15(13):6302-6330. doi: 10.18632/aging.204853.
3
Separating T Cell Targeting Components onto Magnetically Clustered Nanoparticles Boosts Activation.
将 T 细胞靶向成分分离到磁性聚集纳米颗粒上可增强激活。
Nano Lett. 2018 Mar 14;18(3):1916-1924. doi: 10.1021/acs.nanolett.7b05284. Epub 2018 Feb 28.
4
The Basics of Artificial Antigen Presenting Cells in T Cell-Based Cancer Immunotherapies.基于T细胞的癌症免疫疗法中人工抗原呈递细胞的基础
J Immunol Res Ther. 2017;2(1):68-79. Epub 2017 Jun 26.
5
CD47 Enhances In Vivo Functionality of Artificial Antigen-Presenting Cells.CD47增强人工抗原呈递细胞的体内功能。
Clin Cancer Res. 2015 May 1;21(9):2075-83. doi: 10.1158/1078-0432.CCR-14-2696. Epub 2015 Jan 15.
6
T-cell memory responses elicited by yellow fever vaccine are targeted to overlapping epitopes containing multiple HLA-I and -II binding motifs.黄热病疫苗诱导的 T 细胞记忆应答针对的是含有多个 HLA-I 和 -II 结合基序的重叠表位。
PLoS Negl Trop Dis. 2013;7(1):e1938. doi: 10.1371/journal.pntd.0001938. Epub 2013 Jan 31.
7
Induction/engineering, detection, selection, and expansion of clinical-grade human antigen-specific CD8 cytotoxic T cell clones for adoptive immunotherapy.用于过继性免疫治疗的临床级人抗原特异性CD8细胞毒性T细胞克隆的诱导/工程化、检测、筛选及扩增。
J Biomed Biotechnol. 2010;2010:705215. doi: 10.1155/2010/705215. Epub 2010 Mar 10.
8
In vivo administration of artificial antigen-presenting cells activates low-avidity T cells for treatment of cancer.体内给予人工抗原呈递细胞可激活低亲和性 T 细胞用于癌症治疗。
Cancer Res. 2009 Dec 15;69(24):9376-84. doi: 10.1158/0008-5472.CAN-09-0400.
9
A panel of artificial APCs expressing prevalent HLA alleles permits generation of cytotoxic T cells specific for both dominant and subdominant viral epitopes for adoptive therapy.一组表达常见HLA等位基因的人工抗原呈递细胞能够产生针对显性和隐性病毒表位的细胞毒性T细胞,用于过继性治疗。
J Immunol. 2009 Aug 15;183(4):2837-50. doi: 10.4049/jimmunol.0804178. Epub 2009 Jul 27.
10
A reproducible method for the enumeration of functional (cytokine producing) versus non-functional peptide-specific cytotoxic T lymphocytes in human peripheral blood.一种用于计数人外周血中功能性(产生细胞因子的)与非功能性肽特异性细胞毒性T淋巴细胞的可重复方法。
Clin Exp Immunol. 2006 Sep;145(3):438-47. doi: 10.1111/j.1365-2249.2006.03157.x.